ETF Holdings Breakdown of ARVN

Stock NameArvinas Inc
TickerARVN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS04335A1051

News associated with ARVN

Dimensional Fund Advisors LP Buys 186,254 Shares of Arvinas, Inc. (NASDAQ:ARVN)
Dimensional Fund Advisors LP raised its position in shares of Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 28.3% during the 4th quarter, HoldingsChannel.com reports. The fund owned 843,430 shares of the company’s stock after acquiring an additional 186,254 shares during the period. Dimensional Fund Advisors LP’s holdings in Arvinas were worth $16,168,000 as of its […] - 2025-05-09 08:04:57
Voya Investment Management LLC Reduces Holdings in Arvinas, Inc. (NASDAQ:ARVN)
Voya Investment Management LLC lowered its stake in Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 32.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 39,678 shares of the company’s stock after selling 19,312 shares during the quarter. Voya Investment Management LLC owned approximately […] - 2025-05-08 08:26:53
Arvinas (NASDAQ:ARVN) Given New $9.50 Price Target at Citigroup
Arvinas (NASDAQ:ARVN – Get Free Report) had its target price lowered by stock analysts at Citigroup from $10.00 to $9.50 in a research note issued on Monday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. Citigroup’s price target suggests a potential upside of 36.69% from the company’s previous close. ARVN has been […] - 2025-05-07 06:08:49
Arvinas (NASDAQ:ARVN) Receives “Hold” Rating from Truist Financial
Arvinas (NASDAQ:ARVN – Get Free Report)‘s stock had its “hold” rating restated by investment analysts at Truist Financial in a research report issued to clients and investors on Monday, MarketBeat.com reports. They presently have a $11.00 price target on the stock, down from their previous price target of $21.00. Truist Financial’s price objective would suggest […] - 2025-05-07 06:08:47
Arvinas (NASDAQ:ARVN) Price Target Lowered to $10.00 at BMO Capital Markets
Arvinas (NASDAQ:ARVN – Free Report) had its price objective trimmed by BMO Capital Markets from $20.00 to $10.00 in a report released on Monday,Benzinga reports. The firm currently has an outperform rating on the stock. A number of other equities research analysts have also issued reports on ARVN. Piper Sandler reissued an “overweight” rating and […] - 2025-05-06 05:56:43
Arvinas (NASDAQ:ARVN) Given New $24.00 Price Target at HC Wainwright
Arvinas (NASDAQ:ARVN – Free Report) had its target price trimmed by HC Wainwright from $81.00 to $24.00 in a research report released on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. A number of other brokerages have also commented on ARVN. Barclays lowered their price objective on Arvinas from $32.00 […] - 2025-05-05 07:52:55
Barclays PLC Grows Stake in Arvinas, Inc. (NASDAQ:ARVN)
Barclays PLC grew its holdings in Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 43.8% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 175,019 shares of the company’s stock after acquiring an additional 53,320 shares during the period. Barclays PLC’s holdings in Arvinas were worth $3,354,000 at the end of the most recent quarter. […] - 2025-04-29 08:18:56
Arvinas, Inc. (NASDAQ:ARVN) Shares Sold by Federated Hermes Inc.
Federated Hermes Inc. decreased its position in shares of Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 64.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 47,491 shares of the company’s stock after selling 86,719 shares during the […] - 2025-04-16 08:13:03
Wellington Management Group LLP Sells 3,053 Shares of Arvinas, Inc. (NASDAQ:ARVN)
Wellington Management Group LLP lowered its position in Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 9.3% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 29,736 shares of the company’s stock after selling 3,053 shares during the quarter. Wellington Management Group LLP’s holdings in Arvinas were worth $570,000 at the end of the most […] - 2025-04-15 07:46:51
Arvinas, Inc. (NASDAQ:ARVN) Shares Purchased by Schroder Investment Management Group
Schroder Investment Management Group grew its stake in shares of Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 144.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 58,052 shares of the company’s stock after buying an additional 34,283 shares during the period. Schroder Investment Management […] - 2025-04-08 08:12:53
Arvinas (NASDAQ:ARVN) Earns Buy Rating from HC Wainwright
HC Wainwright restated their buy rating on shares of Arvinas (NASDAQ:ARVN – Free Report) in a research report report published on Monday morning,Benzinga reports. They currently have a $81.00 price objective on the stock. ARVN has been the topic of several other reports. The Goldman Sachs Group cut Arvinas from a “buy” rating to a […] - 2025-04-08 05:40:52
Teacher Retirement System of Texas Has $274,000 Stock Position in Arvinas, Inc. (NASDAQ:ARVN)
Teacher Retirement System of Texas raised its position in Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 19.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 14,295 shares of the company’s stock after buying an additional 2,280 shares during the quarter. Teacher Retirement System of Texas’ holdings in Arvinas were worth $274,000 as of its […] - 2025-04-02 07:44:51
Intech Investment Management LLC Has $463,000 Holdings in Arvinas, Inc. (NASDAQ:ARVN)
Intech Investment Management LLC raised its position in Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 69.8% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 24,152 shares of the company’s stock after purchasing an additional 9,926 shares during the period. Intech Investment Management LLC’s holdings in Arvinas were […] - 2025-03-25 09:08:51
Arvinas (NASDAQ:ARVN) Price Target Lowered to $12.00 at Morgan Stanley
Arvinas (NASDAQ:ARVN – Free Report) had its price objective reduced by Morgan Stanley from $48.00 to $12.00 in a report issued on Thursday,Benzinga reports. Morgan Stanley currently has an equal weight rating on the stock. A number of other equities analysts have also recently commented on ARVN. Cantor Fitzgerald reiterated an “overweight” rating on shares […] - 2025-03-14 07:48:58
Arvinas (NASDAQ:ARVN) Price Target Lowered to $32.00 at Guggenheim
Arvinas (NASDAQ:ARVN – Free Report) had its price target decreased by Guggenheim from $57.00 to $32.00 in a research report report published on Thursday morning,Benzinga reports. Guggenheim currently has a buy rating on the stock. A number of other equities analysts also recently commented on the company. Wedbush downgraded Arvinas from an “outperform” rating to […] - 2025-03-14 07:48:56
Arvinas (NASDAQ:ARVN) Downgraded by Wedbush to Neutral
Arvinas (NASDAQ:ARVN – Get Free Report) was downgraded by analysts at Wedbush from an “outperform” rating to a “neutral” rating in a report issued on Wednesday, Marketbeat reports. They presently have a $12.00 price objective on the stock, down from their previous price objective of $57.00. Wedbush’s price target would suggest a potential upside of […] - 2025-03-14 06:34:45
Arvinas (NASDAQ:ARVN) Stock Rating Lowered by Oppenheimer
Arvinas (NASDAQ:ARVN – Get Free Report) was downgraded by analysts at Oppenheimer from an “outperform” rating to a “market perform” rating in a research report issued on Tuesday, Marketbeat Ratings reports. Several other brokerages have also recently weighed in on ARVN. HC Wainwright reaffirmed a “buy” rating and issued a $87.00 price objective on shares […] - 2025-03-13 06:22:59
Arvinas (NASDAQ:ARVN) Given “Buy” Rating at HC Wainwright
Arvinas (NASDAQ:ARVN – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research report issued to clients and investors on Tuesday,Benzinga reports. They currently have a $81.00 price objective on the stock. ARVN has been the subject of several other research reports. Stephens assumed coverage on shares […] - 2025-03-13 06:22:59
Traders Purchase High Volume of Call Options on Arvinas (NASDAQ:ARVN)
Arvinas, Inc. (NASDAQ:ARVN – Get Free Report) was the target of some unusual options trading on Wednesday. Investors purchased 5,428 call options on the stock. This is an increase of approximately 155% compared to the typical volume of 2,130 call options. Insider Buying and Selling at Arvinas In other Arvinas news, insider Ian Taylor sold […] - 2025-03-06 06:18:27
New York State Common Retirement Fund Has $392,000 Holdings in Arvinas, Inc. (NASDAQ:ARVN)
New York State Common Retirement Fund cut its position in shares of Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 9.3% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 20,425 shares of the company’s stock after selling 2,100 shares during the period. New York State Common Retirement Fund’s holdings in Arvinas were worth […] - 2025-03-05 08:42:51
Arvinas, Inc. (NASDAQ:ARVN) Shares Acquired by Rhumbline Advisers
Rhumbline Advisers boosted its stake in Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 0.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 87,877 shares of the company’s stock after acquiring an additional 754 shares during the quarter. Rhumbline Advisers’ holdings in Arvinas were worth $1,685,000 as […] - 2025-03-05 08:11:08
Handelsbanken Fonder AB Boosts Stake in Arvinas, Inc. (NASDAQ:ARVN)
Handelsbanken Fonder AB boosted its stake in shares of Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 16.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 22,825 shares of the company’s stock after buying an additional 3,300 shares during the […] - 2025-03-03 08:59:05
Brokerages Set Arvinas, Inc. (NASDAQ:ARVN) Target Price at $60.00
Shares of Arvinas, Inc. (NASDAQ:ARVN – Get Free Report) have been assigned an average rating of “Buy” from the thirteen ratings firms that are presently covering the stock, MarketBeat.com reports. Thirteen analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have issued ratings on the stock […] - 2025-02-18 06:42:42
Arvinas (NASDAQ:ARVN) Hits New 1-Year Low Following Analyst Downgrade
Arvinas, Inc. (NASDAQ:ARVN – Get Free Report)’s share price reached a new 52-week low on Monday after Barclays lowered their price target on the stock from $48.00 to $32.00. Barclays currently has an overweight rating on the stock. Arvinas traded as low as $16.95 and last traded at $16.72, with a volume of 38455 shares. […] - 2025-02-05 06:20:55

ARVN institutional holdings

The following institutional investment holdings of ARVN have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 40,431USD 275,335 2.1%
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 30,457USD 207,412 2.1%
2025-05-08 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 81,821USD 557,201 2.1%
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 33,439USD 227,720
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 33,439USD 227,720 2.1%
2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 1,400USD 9,534 2.1%
Total =220,987 USD 1,504,922
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.